Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

59 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Tumor marker recovery rather than major pathological response is a preferable prognostic factor in patients with pancreatic ductal adenocarcinoma with preoperative therapy.
Yamada S, Yokoyama Y, Sonohara F, Yamaguchi J, Takami H, Hayashi M, Onoe S, Fujii T, Nagino M, Kodera Y. Yamada S, et al. Among authors: sonohara f. J Hepatobiliary Pancreat Sci. 2020 Aug;27(8):487-495. doi: 10.1002/jhbp.748. Epub 2020 May 14. J Hepatobiliary Pancreat Sci. 2020. PMID: 32359199
Clinical Implications of Lysyl Oxidase-Like Protein 2 Expression in Pancreatic Cancer.
Tanaka N, Yamada S, Sonohara F, Suenaga M, Hayashi M, Takami H, Niwa Y, Hattori N, Iwata N, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujiwara M, Fujii T, Kodera Y. Tanaka N, et al. Among authors: sonohara f. Sci Rep. 2018 Jun 29;8(1):9846. doi: 10.1038/s41598-018-28253-9. Sci Rep. 2018. PMID: 29959362 Free PMC article.
Phase II study of chemoradiotherapy combined with gemcitabine plus nab-paclitaxel for unresectable locally advanced pancreatic ductal adenocarcinoma (NUPAT 05 Trial): study protocol for a single arm phase II study.
Takano N, Yamada S, Hirakawa A, Yokoyama Y, Kawashima H, Maeda O, Okada T, Ohno E, Yamaguchi J, Ishikawa T, Sonohara F, Suenaga M, Takami H, Hayashi M, Niwa Y, Hirooka Y, Ito Y, Naganawa S, Ando Y, Nagino M, Goto H, Fujii T, Kodera Y. Takano N, et al. Among authors: sonohara f. Nagoya J Med Sci. 2019 May;81(2):233-239. doi: 10.18999/nagjms.81.2.233. Nagoya J Med Sci. 2019. PMID: 31239592 Free PMC article. Clinical Trial.
Clinical impact of additional therapy for residual pancreatic cancer.
Yamada S, Sonohara F, Tashiro M, Murotani K, Takami H, Hayashi M, Kanda M, Tanaka C, Kobayashi D, Nakayama G, Koike M, Fujii T, Kodera Y. Yamada S, et al. Among authors: sonohara f. Surg Today. 2020 May;50(5):440-448. doi: 10.1007/s00595-019-01900-y. Epub 2019 Oct 24. Surg Today. 2020. PMID: 31650262
59 results